"The Union for International Cancer Control (UICC) unites and supports the cancer community to reduce the global cancer burden, to promote greater equity, and to ensure that cancer control continues to be a priority in the world health and development agenda."
On 18th June, the National Cancer Center of Korea (NCCK) marks 20 years of commitment to cancer control in the Republic of Korea and to international collaboration. Interview with Dr Hong Gwan Seo, President of NCCK.
The 7th edition of the UICC TNM Atlas has just been published, presenting an illustrated version of the TNM Classification of Malignant Tumours and promoting the uniform application of the TNM classification in cancer practice.
Tobacco use is the leading preventable cause of cancer today. While the regulatory tools exist to reduce it consumption, there are significant financial hurdles to overcome to see effective measures implemented.
Tobacco control is essential to reducing cancer incidence. The first UICC Virtual Dialogue on the topic held on 12th May provided valuable insight into how to unite the efforts of the cancer and tobacco control communities to implement effective regulation.
As pathogens become ever more resistant to antimicrobial drugs such as antibiotics, people living with cancer run a growing risk of adverse treatment outcomes, including death from an infection, even though their cancer is treatable.
Frontline health workers have paid a heavy toll this past year. Marking International Nurses Day, it is important to look to the future and build the support they need to continue their invaluable work.
Effective cancer control includes addressing the risk factors such as tobacco use. UICC fully supports and works with its members to implement the requirements and guidelines of the WHO international treaty on tobacco control.
Dany Habr, Chief Medical Officer, Pfizer Oncology, shares his perspective on what the roll-out of COVID-19 vaccines could mean for the cancer community and the important lessons that Pfizer has learned throughout the pandemic.
A person’s socioeconomic circumstances can impact their risk of cancer, chances of survival and quality of life. Resulting inequities in health must be addressed so that everyone can attain the highest possible standard of health.
In vitro diagnostics offer the opportunity to detect cancer early, for more effective and timely treatment. These quality-assured diagnostics must be available to all those who need them, including in LMICs, for a “fairer, healthier world”.